We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

EU antitrust authorities launch probe of Teva over Copaxone drug

31 2 1

European Union regulators on Thursday announced they have opened a formal investigation into Israel’s Teva Pharmaceuticals for possible antitrust violations.

The European Commission investigation will look into whether the drug company took illegal steps to thwart rivals on its multiple sclerosis medicine Copaxone and abused its dominant market position in breach of EU antitrust rules.

In 2019 and 2020, the European Commission raided the drugmaker, and in November the EU competition enforcer announced a preliminary investigation.

Get The Start-Up Israel's Daily Start-Up by email and never miss our top stories Free Sign Up

“Today, we have decided to launch an in-depth investigation into whether Teva may have abusively blocked or delayed the market entry of competitors to its blockbuster drug Copaxone,” the European commissioner for competition, Margrethe Vestager, said. European Commissioner for Competition Margrethe Vestager addresses a press conference on an antitrust case against US search engine........

© The Times of Israel

Get it on Google Play